Latest / Lung Cancer Considered
FDA Approval: Zongertinib for HER2 Mutant NSCLC
FDA Approval: Zongertinib for HER2 Mutant NSCLC by IASLC
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.
Latest / Lung Cancer Considered
FDA Approval: Zongertinib for HER2 Mutant NSCLC by IASLC
The skinny isn't ready yet — notes appear once the transcript is processed.